Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Literature
1.
Goodman JW, Hodgson GS. Evidence for stem cells in the peripheral blood of mice. Blood. 1962;19:702–14.PubMed
2.
Schwab PJ, Fahey JL. Treatment of Waldenstroms macroglobulinemia by plasmapheresis. New Engl J Med. 1960;263:574–9.CrossRefPubMed
3.
Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980;56:947–58.PubMed
4.
Nicola NA, Metcalf D, Matsumoto M, Johnson GR. Purification of a factor inducing differentiation in murine myelomonocytic leukemia-cells—identification as granulocyte colony-stimulating factor. J Biol Chem. 1983;258:9017–23.PubMed
5.
Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, et al. Purification and biochemical-characterization of human pluripotent hematopoietic colony-stimulating factor. P Natl Acad Sci USA. 1985;82:1526–30.CrossRef
6.
Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony stimulating factor on hematopoietic progenitor cells in cancer-patients. Blood. 1988;72:2074–81.PubMed
7.
Bendall LJ, Bradstock KF. G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev. 2014;25:355–67.CrossRefPubMed
8.
9.
Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004;35:233–45.CrossRefPubMed
10.
11.
12.
Le Texier L, Lineburg KE, MacDonald PA. Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes. Int J Haematol. 2017. doi:10.​1007/​s12185-016-2161-5
13.
Metadata
Title
Factors that influence a mobilized HSC product
Author
Susan K. Nilsson
Publication date
01-02-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2165-1

Other articles of this Issue 2/2017

International Journal of Hematology 2/2017 Go to the issue

Images in Hematology

Chromosomal translocation t(1;22)(q21;q11) in a patient with angioimmunoblastic T-cell lymphoma

Progress in Hematology

Extracellular molecules in hematopoietic stem cell mobilisation

Progress in Hematology

Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes

Case Report

Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia

Progress in Hematology

New agents in HSC mobilization

Case Report

Successful management of perioperative hemostasis in a patient with Glanzmann thrombasthenia who underwent a right total mastectomy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits